Molecular control of retinal stem cell development
视网膜干细胞发育的分子控制
基本信息
- 批准号:7176755
- 负责人:
- 金额:$ 31.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-03-01 至 2009-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAllelesBiochemical GeneticsCell CycleCell LineageCell ProliferationCellsCellular biologyDataDegenerative DisorderDevelopmentDifferentiation and GrowthGene ExpressionGenesGeneticGoalsHomeobox GenesIndividualIntentionKnowledgeLocationModelingMolecularMolecular GeneticsMonitorMusNatural regenerationNeural RetinaNone or Not ApplicableOptic vesicleOutcomePatternPlayProliferatingRangeResearchResearch PersonnelResearch SupportRetinaRetinalRetinal DegenerationRetinal DiseasesRetinal PigmentsRoleSignal TransductionSpecific qualifier valueStagingStem Cell DevelopmentStem Cell ResearchStem cellsStructure of retinal pigment epitheliumTestingTherapeuticTimeTo specifyTransgenic MiceTransgenic OrganismsVisionVisual impairmentWorkbasecell typedesigngene functioninnovationlenslens inductionmouse modelneuroregulationnoveloptic cupoptic stalkprogramsrelating to nervous systemresearch studyretinal progenitor cellretinogenesisself-renewalskillstooltranscription factortransdifferentiation
项目摘要
DESCRIPTION (provided by applicant): Knowledge of the genetic and molecular mechanisms by which the fate of retinal stem cells is determined will be necessary to manipulate the proliferation and differentiation potential of these cells for use in regeneration therapies to treat retinal diseases. We are focused on understanding the genes that control early commitment to neural and pigmented retinal identity with the intention of manipulating these genes to promote regeneration in the mammalian retina and to direct differentiation of specific cell types. Our work with the Rx homeobox gene demonstrates multiple roles for this transcription factor, ranging from initiation of optic vesicle formation, to determining neural retinal identity, and finally, to controlling growth and differentiation of retinal stem cells.
Our long-term goal is to understand how proliferation and differentiation of the mammalian retina are regulated. In pursuit of this goal, the objective of this application is to investigate the role of the Rx gene in controlling the ability of a retinal stem cell to proliferate and differentiate. The central hypothesis of this proposal is that the Rx gene is necessary for determining and maintaining neural retinal cell identity and that it does so by promoting the proliferation of retinal stem cells at multiple stages during retinal development.
The current proposal aims to continue our work on the Rx gene to understand its genetic and biochemical activities in early retinal development. The proposed work is designed in two Specific Aims: 1) to determine if Rx is both necessary and sufficient to specify neural retinal cell identity, using mouse transgenic and conditional deletion models of Rx gene function; and 2) to determine the role of the Rx gene in maintaining neural retinal progenitor proliferation. In this aim, conditional deletion of the Rx gene will be used to uncover its function in the optic cup.
Collectively, these studies will yield important information that is necessary to manipulate endogenous retinal stem cells toward proliferation and ultimate use in restoring sight to the visually impaired.
描述(由申请人提供):对决定视网膜干细胞命运的遗传和分子机制的了解对于操纵这些细胞的增殖和分化潜力以用于治疗视网膜疾病的再生疗法是必要的。我们专注于了解控制早期承诺的神经和色素视网膜的身份与操纵这些基因的意图,以促进在哺乳动物视网膜再生和特定细胞类型的直接分化的基因。我们的工作与Rx同源框基因证明了这种转录因子的多种作用,从启动视泡形成,以确定神经视网膜的身份,最后,控制视网膜干细胞的生长和分化。
我们的长期目标是了解哺乳动物视网膜的增殖和分化是如何调节的。为了实现这一目标,本申请的目的是研究Rx基因在控制视网膜干细胞增殖和分化能力中的作用。该提议的中心假设是Rx基因对于确定和维持神经视网膜细胞身份是必需的,并且其通过在视网膜发育期间的多个阶段促进视网膜干细胞的增殖来实现。
目前的提案旨在继续我们对Rx基因的研究,以了解其在早期视网膜发育中的遗传和生化活动。拟议的工作设计在两个特定的目的:1)确定Rx是否是必要的和足够的,以指定神经视网膜细胞的身份,使用小鼠转基因和条件性缺失模型的Rx基因功能;和2)确定Rx基因在维持神经视网膜祖细胞增殖的作用。在这个目标中,Rx基因的条件性缺失将用于揭示其在视杯中的功能。
总的来说,这些研究将产生重要的信息,这是必要的操纵内源性视网膜干细胞增殖和最终用于恢复视力的视力受损。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter H Mathers其他文献
Peter H Mathers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter H Mathers', 18)}}的其他基金
COBRE: WVU: MOLECULAR REGULATION OF TONOTOPIC ORGANIZATION
COBRE:WVU:主题组织的分子调控
- 批准号:
7170286 - 财政年份:2005
- 资助金额:
$ 31.9万 - 项目类别:
COBRE: WVU: MOLECULAR REGULATION OF TONOTOPIC ORGANIZATION
COBRE:WVU:主题组织的分子调控
- 批准号:
7011721 - 财政年份:2004
- 资助金额:
$ 31.9万 - 项目类别:
MOLECULAR CONTROL OF RETINAL STEM CELL DEVELOPMENT
视网膜干细胞发育的分子控制
- 批准号:
6363162 - 财政年份:1998
- 资助金额:
$ 31.9万 - 项目类别:
MOLECULAR CONTROL OF RETINAL STEM CELL DEVELOPMENT
视网膜干细胞发育的分子控制
- 批准号:
2605218 - 财政年份:1998
- 资助金额:
$ 31.9万 - 项目类别:
MOLECULAR CONTROL OF RETINAL STEM CELL DEVELOPMENT
视网膜干细胞发育的分子控制
- 批准号:
6518589 - 财政年份:1998
- 资助金额:
$ 31.9万 - 项目类别:
Molecular control of retinal stem cell development
视网膜干细胞发育的分子控制
- 批准号:
6870407 - 财政年份:1998
- 资助金额:
$ 31.9万 - 项目类别:
Molecular control of retinal stem cell development
视网膜干细胞发育的分子控制
- 批准号:
7009195 - 财政年份:1998
- 资助金额:
$ 31.9万 - 项目类别:
MOLECULAR CONTROL OF RETINAL STEM CELL DEVELOPMENT
视网膜干细胞发育的分子控制
- 批准号:
6164718 - 财政年份:1998
- 资助金额:
$ 31.9万 - 项目类别:
MOLECULAR CONTROL OF RETINAL STEM CELL DEVELOPMENT
视网膜干细胞发育的分子控制
- 批准号:
2882947 - 财政年份:1998
- 资助金额:
$ 31.9万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 31.9万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 31.9万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 31.9万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 31.9万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 31.9万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 31.9万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 31.9万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 31.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 31.9万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 31.9万 - 项目类别: